Bausch + Lomb wins FDA panel vote for eye implant

04/9/2013 | MassDevice.com (Boston)

A panel of FDA advisers has voted in favor of recommending approval for Bausch + Lomb's Trulign Toric device, designed for patients who have undergone cataract-removal surgery. The posterior chamber intraocular lens is implanted in the eye's capsular bag to visually correct postoperative refractive astigmatism and aphakia in adult patients.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ